0000899243-15-005211.txt : 20150922 0000899243-15-005211.hdr.sgml : 20150922 20150922173019 ACCESSION NUMBER: 0000899243-15-005211 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150922 FILED AS OF DATE: 20150922 DATE AS OF CHANGE: 20150922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENXBIO Inc. CENTRAL INDEX KEY: 0001590877 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9712 MEDICAL CENTER DRIVE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-552-8181 MAIL ADDRESS: STREET 1: 9712 MEDICAL CENTER DRIVE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: REGENXBIO, Inc. DATE OF NAME CHANGE: 20150116 FORMER COMPANY: FORMER CONFORMED NAME: ReGenX Biosciences, LLC DATE OF NAME CHANGE: 20131101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox Allan M. CENTRAL INDEX KEY: 0001652936 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37553 FILM NUMBER: 151119937 MAIL ADDRESS: STREET 1: 9712 MEDICAL CENTER DRIVE STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-22 0 0001590877 REGENXBIO Inc. RGNX 0001652936 Fox Allan M. C/O REGENXBIO INC. 9712 MEDICAL CENTER DRIVE, SUITE 100 ROCKVILLE MD 20850 1 0 1 0 Common Stock 2015-09-22 4 C 0 722485 A 722485 I See Footnote Common Stock 2015-09-22 4 C 0 722485 A 722485 I See Footnote Common Stock 2015-09-22 4 C 0 853915 A 1576400 I See Footnote Common Stock 2015-09-22 4 C 0 478463 A 2054863 I See Footnote Common Stock 443700 I See Footnote Series A Preferred Stock 2015-09-22 4 C 0 722485 0.00 D Common Stock 722485 0 I See Footnote Series A Preferred Stock 2015-09-22 4 C 0 722485 0.00 D Common Stock 722485 0 I See Footnote Series B Preferred Stock 2015-09-22 4 C 0 853915 0.00 D Common Stock 853915 0 I See Footnote Series C Preferred Stock 2015-09-22 4 C 0 478463 0.00 D Common Stock 478463 0 I See Footnote Each share of Preferred Series A, Preferred Series B, and Preferred Series C Stock is convertible and will automatically convert on a 1:1 basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date. The Reporting Person is a trustee of The Allan M. Fox Trust (U/A/D April 21, 2015), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise or such portion of the shares of common stock of the Issuer held by The Allan M. Fox Trust (U/A/D April 21, 2015), in which the Reporting Person has no pecuniary interest. The Reporting Person is a trustee of The Allan M. Fox Revocable Trust, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise or such portion of the shares of common stock of the Issuer held by The Allan M. Fox Revocable Trust, in which the Reporting Person has no pecuniary interest. The Reporting Person holds shared dispositive power over the shares held by FoxKiser Holdings, LLC with John Daniel Kiser, with the Reporting Person having a 60% voting interest in FoxKiser Holdings, LLC. /s/ Allan M. Fox 2015-09-22